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1. Introduction 
  In the past 20 years, more than 35 transdermal delivery systems (TDDSs) have 
been approved in the US, EU, and Japan(Murthy, 2012).  In vitro skin permeation 
experiments are considered to be useful in the development of new TDDSs.  Artificial 
membranes using a parallel artificial membrane permeability assay, PAMPA 
(Akamatsu et al., 2009; Avdeef et al., 2007), and skin-PVPA model (Palac et al., 2014) 
are currently used to select orally administered drug candidates in a short experimental 
period.  However, the selection of compound candidates from a large chemical library is 
time-consuming because the skin permeation rates of chemical compounds are known to 
be markedly lower than those through other mucosal membranes.  Therefore, 
synthesized artificial membranes (Hatanaka et al., 1990; Sugibayashi et al., 2010) and 
three-dimensional cultured human skin models (Kano et al., 2010; Poumay et al., 2004) 
have been used as alternatives to human and animal skins in the development of 
TDDSs.  Previous studies examined the flux or permeability coefficients, P, of chemical 
compounds through alternative membranes and those through excised human or 
animal skin (Kano et al., 2010; Morimoto et al., 1992; Scott et al., 1986).  Sinkó et al., 
recently described (SinkÃ et al., 2012) PAMPA incorporated with human ceramide 
analogues and fatty acids in the stratum corneum.  Although PAMPA could roughly 
predict human skin permeability, a 1:1 correlation was not obtained between the P 
values of chemicals through the synthetic membrane and human skin.  This finding 
suggested that this membrane may not be sufficiently sensitive to reflect the 
physicochemical properties of penetrants. 
The physicochemical properties of drugs, such as their molecular weights and 
the lipophilic/hydrophilic balance (i.e., octanol/ buffer apparent distribution ratio at a 
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particular pH, log Ko/w), have been shown to markedly affect permeability through skin 
(Potts and Guy, 1992; Lian et al., 2008; Riviere and Brooks, 2011).  Most drugs utilized 
in TDDSs have a molecular weight under 500 Daltons (Bos and Meinardi, 2000), and 
the P value through skin was previously reported to markedly decrease with an 
increase in molecular weight over 500 Daltons.  Furthermore, elevations were 
observed in the P values of drugs with an increase in the log Ko/w.  Thus, the P value 
can be further divided into two parameters; diffusion (DL-2) and partition (KL) 
parameters (Okamoto et al., 1988), where D, K and L are the diffusion coefficient, 
partition coefficient, and thickness of the membrane, respectively.  These parameters 
can be easily obtained from in vitro skin permeation experiments, the values of which 
depend on the characteristics as well as penetrant properties of the membrane.  
Therefore, the acquisition of these parameters for alternative membranes may prove 
very useful in understanding membrane characteristics and their similarities (or 
difference) to human and animal skins.  
An in silico approach has also been attempted in order to predict the P values 
of chemical compounds through skin with their physicochemical properties (Potts and 
Guy, 1992); (Lian et al., 2008; Karadzovska et al., 2013).  The predicted P values could 
be used to more easily understand and evaluate the usefulness and safety of topically 
applied chemical compounds. Thus, similarities between the lipophilicity characteristics 
or solubility parameters of alternative membranes and human/animal skins may be 
needed in order to establish a good prediction from various formulations and applied 
conditions (finite or infinite volume condition). 
Strat-M ™ (Merck Millipore, USA) was recently launched and is now 
commercially available as a skin-mimic artificial membrane.  This membrane is 
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composed of multiple layers of polyester sulfone.  However, its potential as an 
alternative membrane for estimating skin permeation has not yet been clarified.   
In the present study, a permeation experiment was performed with Strat-M™, 
human skin, or hairless rat skin in order to obtain P, DL-2, and KL of the applied 
compounds from aqueous solution.  The usefulness and characteristics of Strat-M™ 
were investigated by comparing these parameters between human skin, hairless rat 
skin, and Strat-M ™.   
 
2. Experiment 
2.1. Regent and materials  
Methyl paraben (MP), ethyl paraben (EP), n-propyl paraben (PP), n-butyl 
paraben (BP), isosorbide 5-mononitrate (ISMN), n-propyl p-aminobenzoate (P-PABA), 
and n-butyl p-aminobenzoate (B-PABA) were purchased from Tokyo Chemical Industry 
Co., Ltd. (Tokyo, Japan).  Lidocaine hydrochloride (LID•HCl) was purchased from 
Sigma Aldrich (St. Louis, MO, U.S.A.). Antipyrine (ANP), aminopyrine (AMP), methyl 
p-aminobenzoate (M-PABA), and diisopropyl fluorophosphate (DFP) as an ester 
inhibitor were purchased from Wako Pure Chemical (Osaka, Japan).  Ethyl 
p-aminobenzoate (E-PABA) was purchased from Kanto Chemical Co., Ltd. (Tokyo, 
Japan).  Isosorbide dinitrate (ISDN) was kindly gifted from Tokyo Pharmaceutical 
Industries Industry Co., Ltd. (Tokyo, Japan).  The molecular weights (M.W.) and 
octanol/water coefficients (log Ko/w) of these chemicals are shown in Table 1.  Strat-MTM 
was purchased from Merck Millipore (Billerica, MA, U.S.A.).  All other reagents were 
of HPLC grade and were used without further purification.   
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Table 1 
 
2.2. Experimental animals 
Male hairless rats (WBM/ILA-Ht, 230-280 g) were obtained from the Life 
Science Research Center, Josai University (Sakado, Saitama, Japan) or Ishikawa 
Experimental Animal Laboratories (Fukaya, Saitama, Japan).  All animal experiments 
were performed according to the Ethics Committee of Josai University. 
 
2.3. Excised human skin 
Excised abdominal human skin (60-year-old Caucasian female) with a 
thickness of 545 µm was purchased from Biopredic International (Rennes, France) 
through KAC (Kyoto, Japan).  The use of excised human skin was approved by the 
KAC Ethics Committee for human-derived products. 
 
2.4. Scanning and transmission electron microscopic observations of Strat-M TM  
The cross-sectional structure of Strat-M TM was observed using a scanning 
electron microscope (SEM) (S-3000N; Jeol Ltd., Tokyo, Japan) operating under a high 
vacuum condition after being coated with gold.  Prior to transmission electron 
microscopic observations, Strat-M TM was fixed with 2% osmium tetroxide solution and 
embedded in epoxy resin.  Ultra-thin sections were then prepared with an 
ultramicrotome.  The sections obtained were contrasted with 4% uranyl acetate and 
observed with a transmission electron microscope (JEM1200-Ex; Jeol Ltd.).  The 
thickness of the skin sections was measured using DP2-BSW software (Olympus Co., 
Tokyo, Japan).   
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2.5.  Permeation experiments 
Strat-M TM: Strat-M TM was set in a Franz-type diffusion cell (effective diffusion 
area, 1.77 cm2) and the receiver chamber was maintained at 32°C.  Saturated chemical 
compounds dissolved in pH7.4 phosphate-buffered saline (PBS), pH 5.0 citrate-buffered 
saline, or pH 9.0 carbonate-buffered saline (1.0 mL) and 6.0 mL of the corresponding 
buffer were added to the donor and receiver sides, respectively, in all permeation 
experiments.  The receiver solution was agitated using a stirrer bar and magnetic 
stirrer throughout the experiments.  An aliquot (500 µL) was withdrawn from the 
receiver chamber and the same volume of fresh buffer was added to the chamber to keep 
the volume constant.  The penetrant concentration in the receiver chamber was 
determined by HPLC. 
Human skin: Frozen human skin was thawed at room temperature and 
mounted on a Franz-type diffusion cell.  In the case of the skin permeation 
experiments conducted for ester compounds, DFP in PBS at a concentration of 2.7 
µmol/mL (6 mL) was added to the receiver chamber for 11 h to prevent metabolism after 
skin hydration with PBS.  The skin permeation experiments were then started.  The 
absence of an effect by DFP on the skin permeation of parabens and other compounds 
was reported previously (Ahmed et al., 1996; Sugibayashi et al., 2004; Tamura et al., 
1995). Permeation experiments were carried out for the other chemical compounds after 
skin had been hydrated for 12 h with an appropriate buffer at 32°C.  A penetrant 
solution in buffer was added to the donor chamber, whereas DFP in PBS (0.54 µmol/mL) 
or buffer alone (6 mL each) was added to the receiver chamber to start the permeation 
experiments.  An aliquot (500 µL) was withdrawn from the receiver chamber and the 
same volume of PBS containing DFP or buffer alone was added to the chamber to keep 
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the volume constant.  Other procedures were followed according to the method 
described for Strat-MTM.    
Hairless rat skin: Abdominal skin was cleaned using a wet Kimwipe and 
excised from hairless rats under anesthesia with an i.p. injection of pentobarbital (50 
mg/kg).  Stripped skin was obtained by stripping the stratum corneum off 20-times 
with adhesive tape. 	 To decrease variabilities in skin permeability due to the 
abdominal sites of skin, only skin from the right and left upper abdominal areas were 
used.  Excess fat was trimmed from the excised skin, and the skin sample was set in a 
Franz-type diffusion cell.  The skin permeation experiments were conducted after 60 
min of hydration with the corresponding buffer at 32°C. The other procedures were 
performed with the same experimental method to Strat-M TM.  
 
2.6.  Determination of chemicals  
The same volume of acetonitrile containing parabens was added to the MP, EP, 
PP, BP, AMP, ISMN, ISDN, LID, E-PABA, M-PABA, P-PABA, and B-PABA samples.  
After gentle mixing, the sample was centrifuged for 5 min at 21,500 ×g and 4°C to 
remove proteins and contaminants.  The supernatant was injected onto HPLC.  The 
HPLC system consisted of a pump (LC-10AD; Shimadzu, Kyoto, Japan), Chromatopac 
(C-R6A; Shimadzu), UV detector (SPD-6A; Shimadzu), system controller (SCL-6B; 
Shimadzu), and auto-injector (SIL-7A; Shimadzu).  The LiChroCART®250-4 column 
(KGaA·64271; Merck, Darmstadt, Germany) was maintained at 40°C during the eluting 
mobile phase, 0.1% phosphoric acid : acetonitrile = 75 : 25 for MP and EP, 0.1% 
phosphoric acid : acetonitrile = 55 : 45 for PP and BP, 0.1% phosphoric acid containing 5 
mM sodium dodecyl sulfate : acetonitrile = 50 : 50 for AMP, water : acetonitrile = 55 : 45 
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for ISDN, 0.1% phosphoric acid containing 5 mM sodium 1-heptanesulfonate : 
acetonitrile = 70 : 30 for LID, water : acetonitrile = 90 : 10 for ISMN and water : 
acetonitrile = 80 : 20 for ANP.  The flow rate was adjusted to 1.0 mL/min.  The 
injection volume was 20 µL, and detection was performed at 220 nm for ISMN and 
ISDN, 230 nm for LID, 245 nm for AMP, 254 nm for ANP, and 260 nm for MP, EP, PP 
and BP.  Analyses of E-PABA, M-PABA, P-PABA and B-PABA were carried out with 
gradient elution systems. A solvent program that initially started with 30% acetonitrile 
and 70% phosphoric acid solution (0.1%) was changed linearly (13 min) to acetonitrile 
and phosphoric acid (1 : 1) and held for an additional 10.5 min.  The flow rate was 
maintained at 1.0 mL/min.  The system was gradually returned to the starting 
condition for the next sample.  Peaks were detected at 280 nm.  The Inertsil® ODS-3 
column (4.6 × 150 mm, 5 µm, GL Sciences Inc., Tokyo, Japan) was kept at 40°C. 
 
2.7.  Calculation of membrane permeation parameters  
Permeation parameters, such as the permeability coefficient and partition and 
diffusion coefficients, were calculated from the time course of the cumulative amount of 
chemicals that permeated through membrane by the following equations (Flynn et al., 
1974).  
        
                                  𝐹𝑙𝑢𝑥 = 𝐶𝑣𝐾𝐷𝐿 = 𝑃 ∙ 𝐶𝑣                                                                                                                                                                                                 1                                𝐷𝐿!! = 16𝑇!"#                                                                                                                                                                                                                          2                                𝐾𝐿 = 6𝑇!"#𝑃                                                                                                                                                                                                                               3  
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where Cv is the applied concentration of the chemical.  The lag time, Tlag, was 
calculated from the x-axis (time-axis) intercept of the slope at a steady-state flux for the 
permeation profile of chemical compounds through the membrane.   
 
2.8.  Statistical analysis 
Pearson's correlation coefficient was used to characterize the relationship 
between logP values in human and rat skins and Strat-MTM.  Significance was to 5% in 
all evaluations.   
 
3.  Results 
Figure 1 shows an SEM image of a vertical section of Strat-M TM.   Three 
layers; i, ii, and iii, were confirmed from the figure.  The density of each layer differed 
and gradually decreased from the top of the membrane.  The thicknesses of these 
layers were 52.3 ± 0.5, 76.7 ±?5.07 and 196 ±?7.37 µm (mean ± S.D.) respectively, from 
the top, while that of the whole layer was 324.6 ±?4.6 µm.   
 
Figure 1 
 
Figures 2 a, b and c show TEM images of the 1st, 2nd, and 3rd layers of 
Strat-MTM, respectively.  Staining was observed in the 1st and 2nd layers, but was 
absent in the 3rd layer, suggesting that lipids existed in the top two layers.   
 
Figure 2 
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Figure 3 shows the relationships between logKo/w and log P obtained from 
permeation experiments through human skin, rat skin, or Strat-MTM.  Elevations were 
observed in the log P of all membranes with an increase in lipophilicities of the chemical 
compounds applied.  The relationship obtained between log P and logKo/w could be 
represented by a sigmoidal curve.  The log P values obtained in Strat-MTM were very 
similar to those in human and rat skins. 
 
Figure 3 
 
Figures 4 a, b, and c show the relationship between log P in human and rat 
skins, in rat skin and Strat-MTM, and in human skin and Strat-MTM, respectively and 
permeability coefficients of chemicals through the membranes were shown in Table 2.  
A good relationship was observed between the human and rat skin data, as shown in 
Figure 4a.  Furthermore, the almost 1:1 relationship (slope ≈ 1.0) observed between rat 
and human skin strongly indicated that excised hairless rat could be used as an 
alternative to human skin.  In addition, a good relationship was observed between 
Strat-MTM and human or rat skin; however, the slopes were slightly greater than unity 
because the permeation of chemical compounds through Strat-MTM was slightly faster 
than that through human and hairless rat skins.    
 
Figure 4 
 
Each membrane was characterized using permeation parameters such as 
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logKL and logDL-2.  Figure 5a and b shows the relationship between logKo/w and log KL 
or logDL-2 in Strat-MTM, human and rat skins.  Log KL in the membranes was 
increased with an increase of logKo/w of chemicals and these values were almost the 
same among the membranes, whereas log DL-2 in the membranes had almost the 
constant value despite of different logKo/w of chemicals.    
Figure 6a-d shows the relationship for log KL or log DL-2 between Strat-MTM 
and human or rat skin.  Log KL in Strat-MTM was similar to that in human or rat skin, 
and almost 1:1 slopes were observed between Strat-MTM and human or rat skin.  On 
the other hand, logDL-2 in Strat-MTM shows liner relationships to those in human or rat 
skin with higher logDL-2 values than those in human and rat skins.   
 
Figure 6 
 
4. Discussion 
In vitro permeation experiments using excised human and animal skins are 
very useful for understanding the skin permeation profiles and skin concentrations of 
topically applied chemicals.  However, in vitro experiments using human skin are 
expensive and sometimes limited due to the low availability of samples and ethical 
issues.  Furthermore, animal testing to evaluate the safety and efficacy of cosmetic 
ingredients has been banned by Cosmetic Directive 76/768/EEC.   
The outmost layer, the stratum corneum, has the largest barrier function 
against skin permeation by chemicals (Prausnitz and Langer, 2008; Naik et al., 2000; 
Flynn et al., 1974).  In the present study, the rate-limiting step in the permeation of 
chemicals through Strat-MTM remains unknown because the permeation experiment 
12 
 
could not be performed with each separated layer of Strat-MTM.  Membrane 
permeation profiles can generally be expressed by partition and diffusion phenomena 
(Okamoto et al., 1988).  Chemical compounds are immediately distributed or 
partitioned into the membrane surface following the application of formulations.  Thus, 
the diffusion and partition coefficients of a chemical into a membrane should be 
investigated to clarify the usefulness of the membrane as an alternative to human skin	 
in permeation experiment.   
Elevations were observed in the log P of chemicals through rat and human 
skins and Strat-M TM with an increase in their log Ko/w (Fig. 3), and 1:1 relationships 
were detected between human and rat skins or Strat-M TM (Fig. 4).  Furthermore, log 
KL and log P were similar among membranes at the same log Ko/w of chemicals, 
suggesting that the lipophilicity characteristics or solubility parameters of Strat-M TM 
were close to those of human and rat skins.  These results suggested that skin 
permeation by chemicals may be predicted according to their permeability coefficients 
through Strat-M TM.   
    To further investigate the characteristics of Strat-M TM, the permeability 
coefficients of ionized (Pi) and non-ionized (Pu) lidocaines were compared with those 
through human skin (Kitamura et al., 2009; Hayashi et al., 1992).  These values were 
calculated using skin permeability coefficients at different ratios of the ionized and 
non-ionized forms of the molecule at pH5.0 and pH7.4 in the present study.  Pu and Pi 
obtained from excised human skin were 7.1×10-6 and 4.0×10-8 cm/s, respectively.   Pu 
was 177-fold higher than Pi.  On the other hand, Pu and Pi obtained from Strat-MTM 
were 5.6×10-6 and 1.3×10-7 cm/s, respectively.  Although Pu in Strat-MTM was higher 
than Pi in Strat-MTM, Pu in Strat-MTM was only approximately 43-fold higher than Pu in 
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Strat-MTM.  Pu in human skin was nearly 1.3-fold higher than that in Strat-MTM, 
whereas Pi in Strat-M TM was nearly 3.2-fold higher than that in human skin.  Recent 
studies have described the main permeation pathway of ionized and large molecular 
weight compounds.  However, the contribution of the hydrophilic pathway such as hair 
follicles and sweat ducts to total skin permeation by chemical compounds remains 
unclear.  The main permeation route of ionized compounds may be an aqueous-filled 
pore route due to their high solubility or partition into the aqueous phase.  Higher log 
DL-2 in Strat-M TM was observed in hydrophilic chemicals (log Ko/w<0).  Since, 
diffusivity of chemicals in a membrane is related to its permeation route, low-tortuosity 
of hydrophilic pathway in Strat-MTM might be a reason for higher permeability of 
hydrophilic compounds. To confirm this assumption, further in vitro permeation experiment was 
performed with sodium calcein {M.W.; 644.5, log Ko/w; -3.5 (at pH7.4), pKa; 5.5} and sodium 
fluorescein {M.W.; 376.3, log Ko/w; -0.61 (at pH7.4), pKa; 6.4}.  These permeations through 
Strat-MTM were, however, not observed over 8 h experiment, whereas these were observed in human 
and rat skins (data not shown).  The reason for the non-permeation of these chemicals through 
Strat-M TM might be related to their large molecular sizes.  Therefore, physicochemical 
characteristics of applied chemicals should be considered to use Strat-M TM in a permeation 
experiment.   Further experiment should be performed to reveal the characteristics of aqueous 
pathway in Strat-M TM.   
 
5. Conclusion 
The permeability coefficients of chemical compounds through Strat-MTM can be 
used to predict those through excised human and rat skins, especially for chemical 
compounds with molecular weights between 151 to 288 and logKo/w from -0.90 to 3.53.   
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Thus, Strat-MTM can be utilized in screening tests to estimate the permeability of 
chemicals through human skin.  Further experiments need to be conducted with 
various formulations such as patches, emulsions, and ointments in order to clarify that 
Strat-MTM can be used to determine formulation designs for the topical and/or 
transdermal delivery of compounds. 
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Figure captions. 
 
Figure 1  Scanning electron microscopic image of a cross-section of Strat-MTM. The first 
i), second ii), and third layer iii) of Strat-MTM. 
 
Figure 2  Transmission scanning electron microscopic observation of a cross-section of 
Strat-MTM.  The first i), second ii), and third layer iii) of Strat-MTM.  Lipids in the 
layer were stained with a black color.  Arrows show the lipid region. 
  
Figure 3 Relationships between log Ko/w and log P of applied chemical compounds.  
Symbols; Excised human skin (△), excised hairless rat skin (○), and Strat-M TM (□).  All 
results are expressed as the means ± S.E. (n=3). 
 
Figure 4  Relationships between log P values of human skin and rat skin or Strat-M TM. 
All results are expressed as the means ± S.E. (n=3). Pearson's Correlation Coefficient 
showed significance (P <0.05). 
 
Figure 5  Relationships between log Ko/w and log KL, or log DL-2 of applied chemical 
compounds through human skin and rat skin or Strat-M TM..  Symbols; Excised human 
skin (△), excised hairless rat skin (○), and Strat-M TM (□).  All results are expressed as 
the means ± S.E. (n=3).  
 
Figure 6  Relationships in logKL (a, b) or log D (c, d) between Strat-MTM and human 
skin or rat skin.  (a, c); Strat-MTM vs human skin, (b,d); Strat-MTM vs human skin.  All 
20 
 
results are expressed as the means ± S.E. (n=3). Pearson's Correlation Coefficient 
showed significance (P <0.05).  
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Table 1  Physicochemical properties of the compounds used in the present study 
 Abbreviati
on 
M.W. logKo/w* 
Lidocaine  LID 288.8 
-0.9 (pH5.0) 
1.3 (pH7.9) 
1.4 (pH10) 
Isosorbide 5-mononitrate ISMN 191.1 -0.2 (pH7.4) 
Caffeine CAF 194.2 -0.12 (pH7.4) 
Aminopyrine AMP 231.3 1.1 (pH7.4) 
Isosorbide dinitrate ISDN 236.1 1.2 (pH7.4) 
Methyl paraben MP 152.2 1.9 (pH7.4) 
Ethyl paraben EP 166.1 2.3 (pH7.4) 
n-Propyl paraben PP 180.2 2.8 (pH7.4) 
n-Butyl paraben BP 194.2 3.5 (pH7.4) 
Methyl p-amimobenzoate M-PABA 151.6 1.38 (pH7.4) 
Ethyl p-amimobenzoate E-PABA 165.2 1.89 (pH7.4) 
n-Propyl p-amimobenzoate P-PABA 179.2 2.43 (pH7.4) 
n-Butyl p-amimobenzoate B-PABA 193.2 2.70 (pH7.4) 
*Octanol/buffer partition coefficient of compounds at 32°C. 
pH was adjusted with pH 7.4 phosphate-buffered saline, pH 5.0 citrate-buffered saline, or pH 
9.0 carbonate-buffered saline. 
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